Arianne Schild, MS

Astellas Pharma Global Development
Northbrook, Illinois, United States

Disclosure information not submitted.

Presentation(s):

• SUN-149 - OPTION‑VMS: Preliminary Analysis of A Phase 4 Observational, Real‑World Study of Non‑Hormonal Pharmacotherapies for Bothersome Menopause‑Associated Vasomotor Symptoms and Depression and Anxiety

  Sunday, June 14, 2026
  9:00 AM - 4:00 PM CT